{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:41:20Z","timestamp":1783341680715,"version":"3.54.6"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejmech.2023.115712","type":"journal-article","created":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T20:19:37Z","timestamp":1691353177000},"page":"115712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity"],"prefix":"10.1016","volume":"259","author":[{"given":"Ahmed M.","family":"Shawky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal A.","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf N.","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa G.M.","family":"Youssif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Abdel-Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Hersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany A.M.","family":"El-Sherief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashwa, A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4527-8885","authenticated-orcid":false,"given":"Ahmed M.","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115712_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2023.115712_bib2","first-page":"89","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Przegl\u0105d Gastroenterol."},{"key":"10.1016\/j.ejmech.2023.115712_bib3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2174\/1573406416666200517103435","article-title":"Synthesis of thiazolyl-N-phenylmorpholine derivatives and their biological activities","volume":"17","author":"Al-Soliemy","year":"2021","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13065-020-00694-2","article-title":"Bioactive fluorenes. Part III: 2,7-dichloro-9H-fluorene-based thiazolidinone and azetidinone analogues as anticancer and antimicrobial against multidrug resistant strains agents","volume":"14","author":"Hussein","year":"2020","journal-title":"BMC Chem"},{"key":"10.1016\/j.ejmech.2023.115712_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ph15101164","article-title":"Design, synthesis, in silico testing, and in vitro evaluation of thiazolidinone-based benzothiazole derivatives as inhibitors of \u03b1-amylase and \u03b1-glucosidase","volume":"15","author":"Khan","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115712_bib6","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1016\/j.bmcl.2013.06.051","article-title":"Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines","volume":"23","author":"Sala","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115712_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/1871520615666160504093904","article-title":"Thiazolidinone constraint combretastatin analogs as novel antitubulin agents: design, synthesis, biological evaluation and docking studies","volume":"17","author":"Sharma","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib8","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1016\/j.bmcl.2004.08.029","article-title":"Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer","volume":"14","author":"Gududuru","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115712_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejmech.2014.05.009","article-title":"Synthesis and antiproliferative effect of novel 4-thiazolidinone-, pyridine- and piperazine-based conjugates on human leukemic cells","volume":"81","author":"Sharath Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2014.04.068","article-title":"Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents","volume":"80","author":"Wu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2018.01.143","article-title":"Use of CK-548 and CK-869 as Arp2\/3 complex inhibitors directly suppresses microtubule assembly both in vitro and in vivo","volume":"496","author":"Yamagishi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2023.115712_bib12","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1016\/j.bmcl.2007.07.084","article-title":"Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors","volume":"17","author":"Zarghi","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115712_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0223-5234(99)80060-9","article-title":"2-Substituted-3-(4-bromo-2-carboxyphenyl)-5-methyl-4-thiazolidinones as potential anti-inflammatory agents","volume":"34","author":"Goel","year":"1999","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib14","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/S0960-894X(01)00476-0","article-title":"Synthesis and antiinflammatory, analgesic activity of 3,3\u2019-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10","volume":"11","author":"Vigorita","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115712_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1871523015666160524141630","article-title":"Exploring anti-inflammatory potential of thiazolidinone derivatives of benzenesulfonamide via synthesis, molecular docking and biological evaluation","volume":"15","author":"Bari","year":"2016","journal-title":"Antiinflamm. Antiallergy. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106411","article-title":"Design, Synthesis, Molecular docking, and biological evaluation of novel 2,3-diaryl-1,3-thiazolidine-4-one derivatives as potential anti-inflammatory and cytotoxic agents","author":"Mekhlef","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib17","doi-asserted-by":"crossref","first-page":"26109","DOI":"10.18632\/oncotarget.25450","article-title":"Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models","volume":"9","author":"Punganuru","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2023.115712_bib18","series-title":"Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile","first-page":"12","author":"Basak","year":"2021"},{"key":"10.1016\/j.ejmech.2023.115712_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2017.05.016","article-title":"Designing multi-targeted agents: an emerging anticancer drug discovery paradigm","volume":"136","author":"Fu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib20","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.2174\/1568026617666170707124126","article-title":"Multi-targeted anticancer agents","volume":"17","author":"Zheng","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.980141","article-title":"Editorial: multi-target directed ligands for the treatment of cancer","volume":"12","author":"Brindisi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2023.115712_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092601","article-title":"Hybrid drugs\u2014a strategy for overcoming anticancer drug resistance?","volume":"26","author":"Szumilak","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115712_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fphar.2015.00205","article-title":"Multi-target pharmacology: possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective","volume":"6","author":"Talevi","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115712_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13058-022-01506-2","article-title":"Microtubule disruption reduces metastasis more effectively than primary tumor growth","volume":"24","author":"Thompson","year":"2022","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115712_bib25","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2023.115712_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ph13120463","article-title":"Non-steroidal anti-inflammatory drugs increase cisplatin, paclitaxel, and doxorubicin efficacy against human cervix cancer cells","volume":"13","author":"Robledo-Cadena","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115712_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.lungcan.2004.11.004","article-title":"Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial","volume":"48","author":"Nugent","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejmech.2023.115712_bib28","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/S0753-3322(05)80052-6","article-title":"Taxanes and COX-2 inhibitors: from molecular pathways to clinical practice","volume":"59","author":"Olsen","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2023.115712_bib29","first-page":"403","article-title":"[Celecoxib enhances the chemotherapy sensitivity of KB\/VCR cell lines to vincristine]., Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China","volume":"31","author":"Yan","year":"2013","journal-title":"J. Stomatol."},{"key":"10.1016\/j.ejmech.2023.115712_bib30","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1021\/jm1011534","article-title":"Synthesis and biological evaluation of novel 5-Benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases","volume":"54","author":"Ma","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s41061-020-0298-4","article-title":"Saturated five-membered thiazolidines and their derivatives: from synthesis to biological applications","volume":"378","author":"Sahiba","year":"2020","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib32","first-page":"445","article-title":"Mass spectrometric study of some 2,3-diaryl-1,3-thiazolidin-4-ones under electron impact, Org","volume":"28","author":"Woolston","year":"1993","journal-title":"Mass Spectrom."},{"key":"10.1016\/j.ejmech.2023.115712_bib33","first-page":"1313","article-title":"Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety: design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents","volume":"36","author":"Shawky","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26134002","article-title":"In silico approach using free software to optimize the antiproliferative activity and predict the potential mechanism of action of pyrrolizine-based schiff bases","volume":"26","author":"Almalki","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115712_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/excr.2000.4863","article-title":"Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells","volume":"256","author":"Hsi","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2023.115712_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14728222.2014.860447","article-title":"Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness","volume":"18","author":"Bocca","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2023.115712_bib37","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1038\/sj.onc.1208943","article-title":"Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells","volume":"24","author":"Yang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2023.115712_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.taap.2011.06.019","article-title":"Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells","volume":"255","author":"El-Awady","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115712_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0014-5793(02)03535-4","article-title":"Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells","volume":"531","author":"Yamazaki","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2023.115712_bib40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bcp.2007.09.005","article-title":"Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels","volume":"75","author":"Bijman","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115712_bib41","doi-asserted-by":"crossref","first-page":"39728","DOI":"10.1039\/D1RA07922K","article-title":"Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers","volume":"11","author":"Hagras","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115712_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127468","article-title":"Anti-proliferative potential of triphenyl substituted pyrimidines against MDA-MB-231, HCT-116 and HT-29 cancer cell lines","volume":"30","author":"Ranjan Dwivedi","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115712_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.isci.2019.10.003","article-title":"Structural basis of colchicine-site targeting acylhydrazones active against multidrug-resistant acute lymphoblastic leukemia","volume":"21","author":"Cury","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2023.115712_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/bcr597","article-title":"The future of cytotoxic therapy: selective cytotoxicity based on biology is the key","volume":"5","author":"de Bono","year":"2003","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115712_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cbf.3166","article-title":"A novel microtubule depolymerizing colchicine analogue triggers apoptosis and autophagy in HCT-116 colon cancer cells","volume":"34","author":"Kumar","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ejmech.2023.115712_bib46","doi-asserted-by":"crossref","DOI":"10.3791\/2573","article-title":"Clonogenic assay: adherent cells","author":"Rafehi","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejmech.2023.115712_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204606","article-title":"Significance of targeting VEGFR-2 and cyclin D1 in luminal-A breast cancer","volume":"25","author":"Abdalla","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115712_bib48","doi-asserted-by":"crossref","first-page":"74586","DOI":"10.1039\/C6RA14929D","article-title":"PLGA nanoparticles augmented the anticancer potential of pentacyclic triterpenediol in vivo in mice","volume":"6","author":"Dubey","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115712_bib49","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00210-022-02269-5","article-title":"[1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice","volume":"395","author":"WalyEldeen","year":"2022","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115712_bib50","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.3390\/molecules18066584","article-title":"Indomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilization","volume":"18","author":"Guo","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115712_bib51","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1080\/13102818.2021.1953401","article-title":"Cytotoxic and antiproliferative effects of the nonsteroidal anti-inflammatory drug diclofenac in human tumour cell lines","volume":"35","author":"Marinov","year":"2021","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"10.1016\/j.ejmech.2023.115712_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131232","article-title":"Bioactive fluorenes. Part IV: design, synthesis, and a combined in vitro, in silico anticancer and antibacterial evaluation of new fluorene-heterocyclic sulfonamide conjugates","volume":"1246","author":"Hussein","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115712_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25092220","article-title":"Synergistic anti leukemia effect of a novel Hsp90 and a Pan cyclin dependent kinase inhibitors","volume":"25","author":"Abdalla","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115712_bib54","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1039\/c3md00077j","article-title":"Synthesis and antiproliferative activity of some 3-(pyrid-2-yl)-pyrazolines","volume":"4","author":"Ciupa","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2023.115712_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.941834","article-title":"Enhanced anti-cancer effects of oestrogen and progesterone co-therapy against colorectal cancer in males","volume":"13","author":"Mahbub","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2023.115712_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071582","article-title":"Proapoptotic activity of Achillea membranacea essential oil and its major constituent 1,8-cineole against A2780 ovarian cancer cells","volume":"25","author":"Abdalla","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115712_bib57","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.3892\/mmr.2015.4222","article-title":"Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways","volume":"12","author":"Huang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2023.115712_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127698","article-title":"Progress of tubulin polymerization activity detection methods","volume":"37","author":"Zhu","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115712_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2014.10.001","article-title":"Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents","volume":"57","author":"Abdelazeem","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib60","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115712_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21020201","article-title":"Design, synthesis, and biological evaluation of some novel pyrrolizine derivatives as COX inhibitors with anti-inflammatory\/analgesic activities and low ulcerogenic liability","volume":"21","author":"Gouda","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115712_bib62","doi-asserted-by":"crossref","first-page":"Suppl 3","DOI":"10.1186\/ar4175","article-title":"Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage","volume":"15","author":"Sostres","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2023.115712_bib63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5603\/FM.a2016.0067","article-title":"Quercetin attenuates, indomethacin-induced acute gastric ulcer in rats","volume":"76","author":"Alkushi","year":"2017","journal-title":"Folia Morphol."},{"key":"10.1016\/j.ejmech.2023.115712_bib64","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2147\/DDDT.S354779","article-title":"Analagesic and anti-inflammatory potentials of a less ulcerogenic thiadiazinethione derivative in animal models: biochemical and histochemical correlates","volume":"16","author":"Rahman","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2023.115712_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115281","article-title":"Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers","volume":"252","author":"Yuan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2018.07.029","article-title":"1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: their anti-proliferative & anti-inflammatory activity","volume":"81","author":"Naaz","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib67","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib68","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jmb.2014.02.005","article-title":"The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization","volume":"426","author":"Prota","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115712_bib69","article-title":"Pyrrolizine\/indolizine-cinnamaldehyde Schiff bases: design, synthesis, biological evaluation, ADME, and molecular docking study","author":"Abourehab","year":"2022","journal-title":"Eur. J. Med. Chem. Reports"},{"key":"10.1016\/j.ejmech.2023.115712_bib70","series-title":"Discovery Studio Visualizer, v16.1.0.15350","author":"Dassault systems BIOVIA","year":"2016"},{"key":"10.1016\/j.ejmech.2023.115712_bib71","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejmech.2017.06.045","article-title":"Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6)","volume":"138","author":"Cingolani","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115712_bib72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115712_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115712_bib74","doi-asserted-by":"crossref","first-page":"W53","DOI":"10.1093\/nar\/gku401","article-title":"ProTox: a web server for the in silico prediction of rodent oral toxicity","volume":"42","author":"Drwal","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115712_bib75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2023.115712_bib76","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-018-0324-5","article-title":"BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification","volume":"11","author":"Djoumbou-Feunang","year":"2019","journal-title":"J. Cheminf."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423006797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423006797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:02:00Z","timestamp":1759330920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423006797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":76,"alternative-id":["S0223523423006797"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115712","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115712"}}